Genfit enters collaborations with French pharma companies.

PARIS - Genfit SA, which aims to discover new therapeutic targets by identifying the impairments in gene function behind certain common diseases, signed collaboration agreements with two French pharmaceutical companies, BioMerieux-Pierre Fabre and Laboratoires Fournier.

Lille-based Genfit entered a three-year research collaboration wit BioMerieux-Pierre Fabre, of Lyon, for the identification of the molecular mechanisms of action of new drug candidates for the treatment of cardiovascular diseases.

The deal concluded with Fournier, of Dijon, is for five years and calls for Genfit to identify new therapeutic targets in the field of metabolic diseases. In addition, …